img

Global Rituxan (Rituximab) Monoclonal Antibody Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rituxan (Rituximab) Monoclonal Antibody Market Insights, Forecast to 2034

RITUXAN® (rituximab) is a prescription medicine used to treat Adults with Non-Hodgkin's Lymphoma (NHL)alone or with other chemotherapy medicines. Children 6 months of age and older with mature B-cell Non-Hodgkin's Lymphoma (NHL) and mature B-cell acute leukemia (B-AL)in combination with chemotherapy medicines.
Global Rituxan (Rituximab) Monoclonal Antibody market is expected to reach to US$ 4317 million in 2023, with a positive growth of %, compared with US$ 4125 million in 2024 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Rituxan (Rituximab) Monoclonal Antibody industry is evaluated to reach US$ 5306.7 million in 2034. The CAGR will be 3.5% during 2023 to 2034.
Globally, Rituxan (Rituximab) Monoclonal Antibody key manufacturers include Roche, Teva, Pfizer and Amgen, etc. Roche, Teva, Pfizer are top 3 players and held % sales share in total in 2024.
When considering the consumption regions, % volume of Rituxan (Rituximab) Monoclonal Antibody were sold to North America, Europe and Asia Pacific in 2024. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2034 and the sales share will be % in 2034. Moreover, China, plays a key role in the whole Rituxan (Rituximab) Monoclonal Antibody market and estimated to attract more attentions from industry insiders and investors.
Rituxan (Rituximab) Monoclonal Antibody can be divided into Brand and Biosimilar, etc. Brand is the mainstream product in the market, accounting for % sales share globally in 2024 and the proportion will be % in 2034.
Rituxan (Rituximab) Monoclonal Antibody is widely used in various fields, such as Child and Adult, etc. Child provides greatest supports to the Rituxan (Rituximab) Monoclonal Antibody industry development. In 2024, global % sales of Rituxan (Rituximab) Monoclonal Antibody went into Child filed and the proportion will reach to % in 2034.
Report Covers
This report presents an overview of global Rituxan (Rituximab) Monoclonal Antibody market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global Rituxan (Rituximab) Monoclonal Antibody market with multiple angles. Items like regional sales, revenue from 2018 to 2034 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Roche
Teva
Pfizer
Amgen
Segment by Type
Brand
Biosimilar

Segment by Application


Child
Adult

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2034
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Rituxan (Rituximab) Monoclonal Antibody plant distribution, commercial date of Rituxan (Rituximab) Monoclonal Antibody, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2034 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2034 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2034 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2034 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2034 in China. Product sales and revenue analysis of China from 2018 to 2034
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Rituxan (Rituximab) Monoclonal Antibody introduction, etc. Rituxan (Rituximab) Monoclonal Antibody Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Rituxan (Rituximab) Monoclonal Antibody
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Rituxan (Rituximab) Monoclonal Antibody Product Introduction
1.2 Market by Type
1.2.1 Global Rituxan (Rituximab) Monoclonal Antibody Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Brand
1.2.3 Biosimilar
1.3 Market by Application
1.3.1 Global Rituxan (Rituximab) Monoclonal Antibody Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Child
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales Estimates and Forecasts 2018-2034
2.2 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Region
2.2.1 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Region: 2018 VS 2024 VS 2034
2.2.2 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Region (2018-2023)
2.2.3 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Region (2024-2034)
2.2.4 Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Region (2018-2034)
2.3 Global Rituxan (Rituximab) Monoclonal Antibody Sales Estimates and Forecasts 2018-2034
2.4 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Region
2.4.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Region: 2018 VS 2024 VS 2034
2.4.2 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Region (2018-2023)
2.4.3 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Region (2024-2034)
2.4.4 Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Manufacturers
3.1.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Manufacturers (2018-2023)
3.1.2 Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rituxan (Rituximab) Monoclonal Antibody in 2024
3.2 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Manufacturers
3.2.1 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Manufacturers (2018-2023)
3.2.2 Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Rituxan (Rituximab) Monoclonal Antibody Revenue in 2024
3.3 Global Key Players of Rituxan (Rituximab) Monoclonal Antibody, Industry Ranking, 2021 VS 2024 VS 2023
3.4 Global Rituxan (Rituximab) Monoclonal Antibody Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rituxan (Rituximab) Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rituxan (Rituximab) Monoclonal Antibody, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rituxan (Rituximab) Monoclonal Antibody, Product Offered and Application
3.8 Global Key Manufacturers of Rituxan (Rituximab) Monoclonal Antibody, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Type
4.1.1 Global Rituxan (Rituximab) Monoclonal Antibody Historical Sales by Type (2018-2023)
4.1.2 Global Rituxan (Rituximab) Monoclonal Antibody Forecasted Sales by Type (2024-2034)
4.1.3 Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Type (2018-2034)
4.2 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Type
4.2.1 Global Rituxan (Rituximab) Monoclonal Antibody Historical Revenue by Type (2018-2023)
4.2.2 Global Rituxan (Rituximab) Monoclonal Antibody Forecasted Revenue by Type (2024-2034)
4.2.3 Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Type (2018-2034)
4.3 Global Rituxan (Rituximab) Monoclonal Antibody Price by Type
4.3.1 Global Rituxan (Rituximab) Monoclonal Antibody Price by Type (2018-2023)
4.3.2 Global Rituxan (Rituximab) Monoclonal Antibody Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Application
5.1.1 Global Rituxan (Rituximab) Monoclonal Antibody Historical Sales by Application (2018-2023)
5.1.2 Global Rituxan (Rituximab) Monoclonal Antibody Forecasted Sales by Application (2024-2034)
5.1.3 Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Application (2018-2034)
5.2 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Application
5.2.1 Global Rituxan (Rituximab) Monoclonal Antibody Historical Revenue by Application (2018-2023)
5.2.2 Global Rituxan (Rituximab) Monoclonal Antibody Forecasted Revenue by Application (2024-2034)
5.2.3 Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Application (2018-2034)
5.3 Global Rituxan (Rituximab) Monoclonal Antibody Price by Application
5.3.1 Global Rituxan (Rituximab) Monoclonal Antibody Price by Application (2018-2023)
5.3.2 Global Rituxan (Rituximab) Monoclonal Antibody Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Rituxan (Rituximab) Monoclonal Antibody Market Size by Type
6.1.1 US & Canada Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2018-2034)
6.1.2 US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2018-2034)
6.2 US & Canada Rituxan (Rituximab) Monoclonal Antibody Market Size by Application
6.2.1 US & Canada Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2018-2034)
6.2.2 US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2018-2034)
6.3 US & Canada Rituxan (Rituximab) Monoclonal Antibody Market Size by Country
6.3.1 US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue by Country: 2018 VS 2024 VS 2034
6.3.2 US & Canada Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2034)
6.3.3 US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rituxan (Rituximab) Monoclonal Antibody Market Size by Type
7.1.1 Europe Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2018-2034)
7.1.2 Europe Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2018-2034)
7.2 Europe Rituxan (Rituximab) Monoclonal Antibody Market Size by Application
7.2.1 Europe Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2018-2034)
7.2.2 Europe Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2018-2034)
7.3 Europe Rituxan (Rituximab) Monoclonal Antibody Market Size by Country
7.3.1 Europe Rituxan (Rituximab) Monoclonal Antibody Revenue by Country: 2018 VS 2024 VS 2034
7.3.2 Europe Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2034)
7.3.3 Europe Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rituxan (Rituximab) Monoclonal Antibody Market Size
8.1.1 China Rituxan (Rituximab) Monoclonal Antibody Sales (2018-2034)
8.1.2 China Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034)
8.2 China Rituxan (Rituximab) Monoclonal Antibody Market Size by Application
8.2.1 China Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2018-2034)
8.2.2 China Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Rituxan (Rituximab) Monoclonal Antibody Market Size by Type
9.1.1 Asia Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2018-2034)
9.1.2 Asia Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2018-2034)
9.2 Asia Rituxan (Rituximab) Monoclonal Antibody Market Size by Application
9.2.1 Asia Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2018-2034)
9.2.2 Asia Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2018-2034)
9.3 Asia Rituxan (Rituximab) Monoclonal Antibody Sales by Region
9.3.1 Asia Rituxan (Rituximab) Monoclonal Antibody Revenue by Region: 2018 VS 2024 VS 2034
9.3.2 Asia Rituxan (Rituximab) Monoclonal Antibody Revenue by Region (2018-2034)
9.3.3 Asia Rituxan (Rituximab) Monoclonal Antibody Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Market Size by Type
10.1.1 Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Market Size by Application
10.2.1 Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Sales by Country
10.3.1 Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue by Country: 2018 VS 2024 VS 2034
10.3.2 Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Overview
11.1.3 Roche Rituxan (Rituximab) Monoclonal Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Roche Rituxan (Rituximab) Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Overview
11.2.3 Teva Rituxan (Rituximab) Monoclonal Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Teva Rituxan (Rituximab) Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Rituxan (Rituximab) Monoclonal Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Pfizer Rituxan (Rituximab) Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Overview
11.4.3 Amgen Rituxan (Rituximab) Monoclonal Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Amgen Rituxan (Rituximab) Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amgen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rituxan (Rituximab) Monoclonal Antibody Industry Chain Analysis
12.2 Rituxan (Rituximab) Monoclonal Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rituxan (Rituximab) Monoclonal Antibody Production Mode & Process
12.4 Rituxan (Rituximab) Monoclonal Antibody Sales and Marketing
12.4.1 Rituxan (Rituximab) Monoclonal Antibody Sales Channels
12.4.2 Rituxan (Rituximab) Monoclonal Antibody Distributors
12.5 Rituxan (Rituximab) Monoclonal Antibody Customers
13 Market Dynamics
13.1 Rituxan (Rituximab) Monoclonal Antibody Industry Trends
13.2 Rituxan (Rituximab) Monoclonal Antibody Market Drivers
13.3 Rituxan (Rituximab) Monoclonal Antibody Market Challenges
13.4 Rituxan (Rituximab) Monoclonal Antibody Market Restraints
14 Key Findings in The Global Rituxan (Rituximab) Monoclonal Antibody Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Rituxan (Rituximab) Monoclonal Antibody Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Brand
Table 3. Major Manufacturers of Biosimilar
Table 4. Global Rituxan (Rituximab) Monoclonal Antibody Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Region (2018-2023)
Table 9. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Region (2024-2034)
Table 10. Global Rituxan (Rituximab) Monoclonal Antibody Sales Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 11. Global Rituxan (Rituximab) Monoclonal Antibody Sales by Region (2018-2023) & (K Units)
Table 12. Global Rituxan (Rituximab) Monoclonal Antibody Sales by Region (2024-2034) & (K Units)
Table 13. Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Region (2018-2023)
Table 14. Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Region (2024-2034)
Table 15. Global Rituxan (Rituximab) Monoclonal Antibody Sales by Manufacturers (2018-2023) & (K Units)
Table 16. Global Rituxan (Rituximab) Monoclonal Antibody Sales Share by Manufacturers (2018-2023)
Table 17. Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Rituxan (Rituximab) Monoclonal Antibody, Industry Ranking, 2021 VS 2024 VS 2023
Table 20. Rituxan (Rituximab) Monoclonal Antibody Price by Manufacturers 2018-2023 (US$/Unit)
Table 21. Global Rituxan (Rituximab) Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Rituxan (Rituximab) Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rituxan (Rituximab) Monoclonal Antibody as of 2024)
Table 23. Global Key Manufacturers of Rituxan (Rituximab) Monoclonal Antibody, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Rituxan (Rituximab) Monoclonal Antibody, Product Offered and Application
Table 25. Global Key Manufacturers of Rituxan (Rituximab) Monoclonal Antibody, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2018-2023) & (K Units)
Table 28. Global Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2024-2034) & (K Units)
Table 29. Global Rituxan (Rituximab) Monoclonal Antibody Sales Share by Type (2018-2023)
Table 30. Global Rituxan (Rituximab) Monoclonal Antibody Sales Share by Type (2024-2034)
Table 31. Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Share by Type (2018-2023)
Table 34. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Share by Type (2024-2034)
Table 35. Rituxan (Rituximab) Monoclonal Antibody Price by Type (2018-2023) & (US$/Unit)
Table 36. Global Rituxan (Rituximab) Monoclonal Antibody Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2018-2023) & (K Units)
Table 38. Global Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2024-2034) & (K Units)
Table 39. Global Rituxan (Rituximab) Monoclonal Antibody Sales Share by Application (2018-2023)
Table 40. Global Rituxan (Rituximab) Monoclonal Antibody Sales Share by Application (2024-2034)
Table 41. Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Share by Application (2018-2023)
Table 44. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Share by Application (2024-2034)
Table 45. Rituxan (Rituximab) Monoclonal Antibody Price by Application (2018-2023) & (US$/Unit)
Table 46. Global Rituxan (Rituximab) Monoclonal Antibody Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. US & Canada Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2018-2023) & (K Units)
Table 48. US & Canada Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2024-2034) & (K Units)
Table 49. US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2018-2023) & (K Units)
Table 52. US & Canada Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2024-2034) & (K Units)
Table 53. US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 56. US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2023) & (K Units)
Table 59. US & Canada Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2024-2034) & (K Units)
Table 60. Europe Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2018-2023) & (K Units)
Table 61. Europe Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2024-2034) & (K Units)
Table 62. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2018-2023) & (K Units)
Table 65. Europe Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2024-2034) & (K Units)
Table 66. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 69. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2023) & (K Units)
Table 72. Europe Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2024-2034) & (K Units)
Table 73. China Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2018-2023) & (K Units)
Table 74. China Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2024-2034) & (K Units)
Table 75. China Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2018-2023) & (K Units)
Table 78. China Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2024-2034) & (K Units)
Table 79. China Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2018-2023) & (K Units)
Table 82. Asia Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2024-2034) & (K Units)
Table 83. Asia Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2018-2023) & (K Units)
Table 86. Asia Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2024-2034) & (K Units)
Table 87. Asia Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Rituxan (Rituximab) Monoclonal Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 90. Asia Rituxan (Rituximab) Monoclonal Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Rituxan (Rituximab) Monoclonal Antibody Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Rituxan (Rituximab) Monoclonal Antibody Sales by Region (2018-2023) & (K Units)
Table 93. Asia Rituxan (Rituximab) Monoclonal Antibody Sales by Region (2024-2034) & (K Units)
Table 94. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2018-2023) & (K Units)
Table 95. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2024-2034) & (K Units)
Table 100. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2024-2034) & (K Units)
Table 107. Roche Company Information
Table 108. Roche Description and Major Businesses
Table 109. Roche Rituxan (Rituximab) Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Roche Rituxan (Rituximab) Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Roche Recent Developments
Table 112. Teva Company Information
Table 113. Teva Description and Major Businesses
Table 114. Teva Rituxan (Rituximab) Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Teva Rituxan (Rituximab) Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Teva Recent Developments
Table 117. Pfizer Company Information
Table 118. Pfizer Description and Major Businesses
Table 119. Pfizer Rituxan (Rituximab) Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Pfizer Rituxan (Rituximab) Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Pfizer Recent Developments
Table 122. Amgen Company Information
Table 123. Amgen Description and Major Businesses
Table 124. Amgen Rituxan (Rituximab) Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Amgen Rituxan (Rituximab) Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Amgen Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Rituxan (Rituximab) Monoclonal Antibody Distributors List
Table 130. Rituxan (Rituximab) Monoclonal Antibody Customers List
Table 131. Rituxan (Rituximab) Monoclonal Antibody Market Trends
Table 132. Rituxan (Rituximab) Monoclonal Antibody Market Drivers
Table 133. Rituxan (Rituximab) Monoclonal Antibody Market Challenges
Table 134. Rituxan (Rituximab) Monoclonal Antibody Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Rituxan (Rituximab) Monoclonal Antibody Product Picture
Figure 2. Global Rituxan (Rituximab) Monoclonal Antibody Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Rituxan (Rituximab) Monoclonal Antibody Market Share by Type in 2024 & 2034
Figure 4. Brand Product Picture
Figure 5. Biosimilar Product Picture
Figure 6. Global Rituxan (Rituximab) Monoclonal Antibody Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Rituxan (Rituximab) Monoclonal Antibody Market Share by Application in 2024 & 2034
Figure 8. Child
Figure 9. Adult
Figure 10. Rituxan (Rituximab) Monoclonal Antibody Report Years Considered
Figure 11. Global Rituxan (Rituximab) Monoclonal Antibody Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Rituxan (Rituximab) Monoclonal Antibody Revenue 2018-2034 (US$ Million)
Figure 13. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 14. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Region (2018-2034)
Figure 15. Global Rituxan (Rituximab) Monoclonal Antibody Sales 2018-2034 ((K Units)
Figure 16. Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Region (2018-2034)
Figure 17. US & Canada Rituxan (Rituximab) Monoclonal Antibody Sales YoY (2018-2034) & (K Units)
Figure 18. US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Rituxan (Rituximab) Monoclonal Antibody Sales YoY (2018-2034) & (K Units)
Figure 20. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Rituxan (Rituximab) Monoclonal Antibody Sales YoY (2018-2034) & (K Units)
Figure 22. China Rituxan (Rituximab) Monoclonal Antibody Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Asia (excluding China) Rituxan (Rituximab) Monoclonal Antibody Sales YoY (2018-2034) & (K Units)
Figure 24. Asia (excluding China) Rituxan (Rituximab) Monoclonal Antibody Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Sales YoY (2018-2034) & (K Units)
Figure 26. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Rituxan (Rituximab) Monoclonal Antibody Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
Figure 28. The Top 5 and 10 Largest Manufacturers of Rituxan (Rituximab) Monoclonal Antibody in the World: Market Share by Rituxan (Rituximab) Monoclonal Antibody Revenue in 2024
Figure 29. Global Rituxan (Rituximab) Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 30. Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Type (2018-2034)
Figure 31. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Type (2018-2034)
Figure 32. Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Application (2018-2034)
Figure 33. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Application (2018-2034)
Figure 34. US & Canada Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Type (2018-2034)
Figure 35. US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Type (2018-2034)
Figure 36. US & Canada Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Application (2018-2034)
Figure 37. US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Application (2018-2034)
Figure 38. US & Canada Rituxan (Rituximab) Monoclonal Antibody Revenue Share by Country (2018-2034)
Figure 39. US & Canada Rituxan (Rituximab) Monoclonal Antibody Sales Share by Country (2018-2034)
Figure 40. U.S. Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 41. Canada Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 42. Europe Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Type (2018-2034)
Figure 43. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Type (2018-2034)
Figure 44. Europe Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Application (2018-2034)
Figure 45. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Application (2018-2034)
Figure 46. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue Share by Country (2018-2034)
Figure 47. Europe Rituxan (Rituximab) Monoclonal Antibody Sales Share by Country (2018-2034)
Figure 48. Germany Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 49. France Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 50. U.K. Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 51. Italy Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 52. Russia Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 53. China Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Type (2018-2034)
Figure 54. China Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Type (2018-2034)
Figure 55. China Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Application (2018-2034)
Figure 56. China Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Application (2018-2034)
Figure 57. Asia Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Type (2018-2034)
Figure 58. Asia Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Type (2018-2034)
Figure 59. Asia Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Application (2018-2034)
Figure 60. Asia Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Application (2018-2034)
Figure 61. Asia Rituxan (Rituximab) Monoclonal Antibody Revenue Share by Region (2018-2034)
Figure 62. Asia Rituxan (Rituximab) Monoclonal Antibody Sales Share by Region (2018-2034)
Figure 63. Japan Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 64. South Korea Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 65. China Taiwan Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 66. Southeast Asia Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 67. India Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Type (2018-2034)
Figure 69. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Type (2018-2034)
Figure 70. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Application (2018-2034)
Figure 71. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Application (2018-2034)
Figure 72. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue Share by Country (2018-2034)
Figure 73. Middle East, Africa and Latin America Rituxan (Rituximab) Monoclonal Antibody Sales Share by Country (2018-2034)
Figure 74. Brazil Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 75. Mexico Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 76. Turkey Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 77. Israel Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 78. GCC Countries Rituxan (Rituximab) Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 79. Rituxan (Rituximab) Monoclonal Antibody Value Chain
Figure 80. Rituxan (Rituximab) Monoclonal Antibody Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed